These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 19696633)
1. Mycophenolic acid impedes the antigen presenting and lymph node homing capacities of human blood myeloid dendritic cells. Cicinnati VR; Hou J; Lindemann M; Horn PA; Sotiropoulos GC; Paul A; Gerken G; Beckebaum S Transplantation; 2009 Aug; 88(4):504-13. PubMed ID: 19696633 [TBL] [Abstract][Full Text] [Related]
2. Mycophenolic acid-treated human dendritic cells have a mature migratory phenotype and inhibit allogeneic responses via direct and indirect pathways. Lagaraine C; Hoarau C; Chabot V; Velge-Roussel F; Lebranchu Y Int Immunol; 2005 Apr; 17(4):351-63. PubMed ID: 15710908 [TBL] [Abstract][Full Text] [Related]
3. Peripheral blood dendritic cells in human end-stage heart failure and the early post-transplant period: evidence for systemic Th1 immune responses. Athanassopoulos P; Vaessen LM; Maat AP; Balk AH; Weimar W; Bogers AJ Eur J Cardiothorac Surg; 2004 Apr; 25(4):619-26. PubMed ID: 15037281 [TBL] [Abstract][Full Text] [Related]
4. Mycophenolic acid upregulates B7-DC expression on dendritic cells, which is associated with impaired allostimulatory capacity of dendritic cells. Geng L; Jiang G; Xie H; Fang Y; Dong S; Chen Y; Shen M; Zheng S Transplant Proc; 2006 Jun; 38(5):1622-4. PubMed ID: 16797370 [TBL] [Abstract][Full Text] [Related]
5. [Effect of mycophenolic acid on maturation, endocytotic capacity and allostimulatory properties of human myeloid dendritic cell]. Hou J; Tang DN; Xu Y; Wei JM; He XW; Li YG Zhonghua Yi Xue Za Zhi; 2010 Jul; 90(27):1910-3. PubMed ID: 20979910 [TBL] [Abstract][Full Text] [Related]
6. Immunosuppressant effect of IDS 30, a stinging nettle leaf extract, on myeloid dendritic cells in vitro. Broer J; Behnke B J Rheumatol; 2002 Apr; 29(4):659-66. PubMed ID: 11950004 [TBL] [Abstract][Full Text] [Related]
7. Vitamin D3-mediated alterations to myeloid dendritic cell trafficking in vivo expand the scope of their antigen presenting properties. Enioutina EY; Bareyan D; Daynes RA Vaccine; 2007 Jan; 25(7):1236-49. PubMed ID: 17092617 [TBL] [Abstract][Full Text] [Related]
8. Characterization of human liver dendritic cells in liver grafts and perfusates. Bosma BM; Metselaar HJ; Mancham S; Boor PP; Kusters JG; Kazemier G; Tilanus HW; Kuipers EJ; Kwekkeboom J Liver Transpl; 2006 Mar; 12(3):384-93. PubMed ID: 16498646 [TBL] [Abstract][Full Text] [Related]
9. Interferon-alpha differentially affects homeostasis of human plasmacytoid and myeloid dendritic cells. Cicinnati VR; Kang J; Hou J; Lindemann M; Koop K; Tüting T; Gerken G; Beckebaum S J Interferon Cytokine Res; 2009 Mar; 29(3):145-60. PubMed ID: 19196069 [TBL] [Abstract][Full Text] [Related]
10. Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation. Yang D; Chen Q; Gertz B; He R; Phulsuksombati M; Ye RD; Oppenheim JJ J Leukoc Biol; 2002 Sep; 72(3):598-607. PubMed ID: 12223529 [TBL] [Abstract][Full Text] [Related]
11. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival. Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829 [TBL] [Abstract][Full Text] [Related]